JY
MR

Jeff Yass’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Jeff Yass’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-115,600
Closed -$3.13M – 10276
2015
Q4 		$3.13M Buy
115,600
+37,600
+48% +$969K ﹤0.01% 3203
2015
Q3 		$1.71M Sell
78,000
-25,500
-25% -$651K ﹤0.01% 4601
2015
Q2 		$2.95M Buy
103,500
+93,200
+905% +$2.72M ﹤0.01% 3888
2015
Q1 		$282K Sell
10,300
-13,400
-57% -$369K ﹤0.01% 8079
2014
Q4 		$626K Sell
23,700
-20,100
-46% -$588K ﹤0.01% 6810
2014
Q3 		$1.32M Sell
43,800
-64,000
-59% -$1.98M ﹤0.01% 5379
2014
Q2 		$3.4M Sell
107,800
-40,800
-27% -$1.29M ﹤0.01% 3692
2014
Q1 		$4.81M Sell
148,600
-23,000
-13% -$805K ﹤0.01% 2947
2013
Q4 		$6.24M Sell
171,600
-42,600
-20% -$1.66M ﹤0.01% 2635
2013
Q3 		$8.33M Buy
214,200
+122,100
+133% +$4.92M ﹤0.01% 2092
2013
Q2 		$3.45M Buy
+92,100
New +$3.64M ﹤0.01% 3096

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jeff Yass's MR Position: Q1 2016 in Review

Jeff Yass sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 104,111 shares — an estimated $2.82M sold.

Jeff Yass first reported a position in MR in Q4 2013 and held it in 8 quarters. The position peaked at $7.14M in Q1 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Jeff Yass reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Jeff Yass sold 104,111 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $2.82M.
  • Jeff Yass first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 8 quarters.
  • Jeff Yass's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $7.14M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Susquehanna International Group's 13F filing for Q1 2016, filed 13 May 2016.